Sarah Cannon Research Institute
Lauren Pilny is a seasoned professional in business development with extensive experience at the Sarah Cannon Research Institute, where roles have included Director and Manager of Business Development, overseeing portfolio management and driving new business opportunities since November 2019. Prior positions in the organization included Strategic Account Manager and Business Development Coordinator, along with earlier roles as Project Manager at Status:Go and various administrative positions at Sarah Cannon. Lauren holds a Bachelor of Fine Arts in Commercial Music from Belmont University, obtained in 2009.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.